Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Debt to Equity (2016 - 2025)

Nutex Health's Debt to Equity history spans 11 years, with the latest figure at $0.12 for Q2 2025.

  • For Q2 2025, Debt to Equity fell 73.8% year-over-year to $0.12; the TTM value through Jun 2025 reached $0.12, down 73.8%, while the annual FY2024 figure was $0.2, 47.9% down from the prior year.
  • Debt to Equity for Q2 2025 was $0.12 at Nutex Health, down from $0.14 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.47 in Q3 2024 and bottomed at $0.0 in Q3 2021.
  • The 5-year median for Debt to Equity is $0.2 (2024), against an average of $0.22.
  • The largest YoY upside for Debt to Equity was 40358.16% in 2021 against a maximum downside of 99.61% in 2021.
  • A 5-year view of Debt to Equity shows it stood at $0.41 in 2021, then tumbled by 48.19% to $0.21 in 2022, then skyrocketed by 75.88% to $0.38 in 2023, then crashed by 47.9% to $0.2 in 2024, then tumbled by 40.16% to $0.12 in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Debt to Equity are $0.12 (Q2 2025), $0.14 (Q1 2025), and $0.2 (Q4 2024).